ÈÕ±¾avÉ«ÇéƬ

Sallie Permar, M.D., Ph.D.

Pediatric Infectious Diseases

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Freedom
  • Liberty
  • Metro/Core/Charter
  • Community Plan
  • HMO
Personal Statement

Dr. Permar is an infectious disease specialist who cares for hospitalized patients only. 

I am passionate about giving children the best possible start to a full and healthy life. As chair and pediatrician-in-chief, I am committed to bringing the engines of medical care, research, and education closer together—translating our findings from the lab to the clinic, and teaching the next generation of physicians and pediatrician-scientists.

Biographical Info

Sallie Permar, M.D., Ph.D is an eminent physician-scientist who focuses on the treatment and prevention of neonatal viral infections. She serves as Chair of the Department of Pediatrics at ÈÕ±¾avÉ«ÇéƬ and Pediatrician-in-Chief at NewYork-Presbyterian/ÈÕ±¾avÉ«ÇéƬ Medical Center and NewYork-Presbyterian Komansky Children’s Hospital.  She is also the Nancy C. Paduano Professor in Pediatrics at ÈÕ±¾avÉ«ÇéƬ and Professor of Immunology and Microbial Pathogenesis at the ÈÕ±¾avÉ«ÇéƬ Graduate School.

As a physician-scientist focusing on the prevention and treatment of neonatal viral infections, Dr. Permar leads a research laboratory investigating immune protection against vertical transmission of neonatal viral pathogens, namely HIV and cytomegalovirus (CMV).  She has made important contributions to the development of vaccines for prevention of vertical HIV transmission, defining both innate and adaptive immune responses that are associated with protection against infant HIV acquisition.  Moreover, Dr. Permar is leading the development of HIV vaccine strategies in preclinical maternal/infant nonhuman primate models and translation of this work for clinical vaccine trials in infants. Dr. Permar has also defined determinants of congenital and perinatal CMV transmission, developing the first nonhuman primate model of congenital CMV infection and leading human cohort studies that have defined immune correlates of protection necessary to guide vaccine development. 

She has received several prestigious investigator awards, including the Presidential Early Career Award in Science and Engineering (PECASE), the E. Mead Johnson Award from the Society of Pediatric Research, and was inducted into the American Society of Clinical Investigation (ASCI) and is a Fellow of the American Academy of Microbiology (AAM) and the American Association of Advancement of Science. In 2020, she received the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America and the Gale and Ira Drukier Prize in Children’s Health Research, and in 2022, Dr. Permar received the Excellence in Science Mid-Career Investigator Award from the Federation of Societies for Experimental Biology (FASEB).  Dr. Permar also serves on the board of the National CMV Foundation, advocating for more awareness and research funding to eliminate this common congenital infection. She is an institutional and national leader in physician-scientist training, serving as the Director of the nearly four decades-old National Institute of Child Health and Development (NICHD) Pediatric Scientist Development Program sponsored by the Association of Medical School Department Chairs of Pediatrics (AMSPDC).

In addition, Dr. Permar serves as the Vice Chair of the Operations Committee and Chair of a Health Equity Task Force in the ÈÕ±¾avÉ«ÇéƬ Physician Organization, aiming to bring these principles of health equity to all patients served by the institution.

Dr. Permar has a Ph.D. in Microbiology/Immunology from Johns Hopkins Bloomberg School of Public Health in Baltimore, an M.D. from Harvard Medical School, and completed her clinical training in pediatric infectious diseases at Children’s Hospital in Boston. She has received several prestigious investigator awards, including the Presidential Early Career Award in Science and Engineering (PECASE), the E. Mead Johnson Award from the Society of Pediatric Research, and was inducted into the American Society of Clinical Investigation (ASCI) and is a Fellow of the American Academy of Microbiology (AAM) and the American Association of Advancement of Science.  In 2020, she received the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America.  Dr. Permar also serves on the board of the National CMV Foundation. She is an institutional and national leader in physician-scientist training, serving as the Director of the National Institute of Child Health and Development (NICHD) Pediatric Scientist Development Program.

Honors and Awards

2022, Excellence in Science Mid-Career Investigator Award, FASEB

2021,  E. Mead Johnson Award, Society for Pediatric Research 
2020, American Association for the Advancement of Science (AAAS) Elected Fellow 

2020, Oswald Avery Award for Early Achievement, Infectious Diseases Society of America 

2020, Gale and Ira Drukier Prize, Drukier Institute for Children’s Health at ÈÕ±¾avÉ«ÇéƬ 

2018, Duke University Research Mentoring Award for Translational Research 

2018, American Academy of Microbiology Fellow 

2018, Duke University Research Mentoring Award for Translational Research 

2017, Duke University School of Medicine Mentoring Award Nominee 

2017, Davidson College Distinguished Alumna Award 

2017, American Pediatric Society Elected Member 

2016, American Society of Clinical Investigation inductee, New Member Speaker 

2015, Pediatric Infectious Diseases Society Young Investigator Award 

2014, Society for Pediatric Research Young Investigator Award 

2014, Ruth and A. Morris Williams Faculty Clinical Research Prize, Duke University Medical Center 

2013, Presidential Award for Early Career Scientists and Engineers (PECASE) 

2012, National Institute of Health Director’s New Innovator Award 

2011, Distinguished Scientist Award, Duke University Medical Center 

2009, Society for Pediatric Research Fellow Basic Science Research Award 

2009, Maxwell Finland Infectious Disease Fellow Research Award 

2009, Eleanor and Miles Shore Fellowship for Scholars in Medicine, Harvard Medical School 

2007, Pediatric Infectious Disease Society/St. Jude Children’s Hospital Fellowship in Basic Research 

2006, Society for Pediatric Research House Officer Research Award 

2006, Yale Johnson and Johnson International Physician Scholar  

2004, Louis Pasteur Clinical Research Award, Harvard Medical School 

2004, Magna Cum Laude, Harvard Medical School 

2001, R. Bradley Sack Award, Bloomberg School of Public Health 
1997,
Fulbright Fellowship, University Teaching Hospital, Lusaka, Zambia. 

Board Certifications
American Board of Pediatrics
American Board of Pediatrics (Pediatric Infectious Diseases)
Clinical Expertise
CMV Infection
HIV
Cytomegalovirus (CMV) Infection
Languages
English
Research
Education 
  • M.D.
    Harvard Medical School
    2004
  • Ph.D.
    The Johns Hopkins University
    2004
  • B.S.
    Davidson College
    1997
Appointments 
  • Pediatrician-in-Chief
    NewYork-Presbyterian Hospital
  • Chair of Pediatrics
    ÈÕ±¾avÉ«ÇéƬ Medical College, Cornell University
  • Nancy C. Paduano Professor in Pediatrics
    ÈÕ±¾avÉ«ÇéƬ Medical College, Cornell University
  • Professor of Pediatrics
    ÈÕ±¾avÉ«ÇéƬ Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant: 
Dynavax Technologies
GlaxoSmithKline
Merck & Co., Inc.
ModernaTX
Pfizer, Inc.
Professional Services: 
Medscape, LLC